Related Experiment Video
Updated: Jun 24, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
Screening of candidated molecular markers in polymyositis using GenMAPP software
1Department of Dermatology, Xiangya Hospital, Central South University, Changsha 410008, China. zhuwu1970@yahoo.cn
This study identified 119 differentially expressed genes in polymyositis (PM), including key molecular markers like NF-kappaB, TNF-alpha, and IL-1alpha. These findings advance understanding of PM pathogenesis and potential therapeutic targets.
Area of Science:
- Molecular Biology
- Immunology
- Genetics
Background:
- Polymyositis (PM) is an idiopathic inflammatory myopathy.
- Identifying molecular markers is crucial for understanding PM pathogenesis and developing targeted therapies.
Purpose of the Study:
- To screen and identify candidate molecular markers in polymyositis.
- To analyze differential gene expression profiles in PM muscle tissue.
Main Methods:
- Gene expression profiling using microarrays.
- Analysis with Gene MicroArray Pathway Profiler (GenMAPP) software.
- Validation of differentially expressed genes by real-time quantitative RT-PCR and Western blot.
Main Results:
- Identified 119 differentially expressed genes in PM muscle tissue compared to normal controls.
- Found 64 genes upregulated and 47 genes downregulated, associated with cell proliferation, signal transduction, cell cycle, gene transcription, and DNA repair.
- Confirmed significant upregulation of NF-kappaB, TNF-alpha, and IL-1alpha gene expression in PM.
Conclusions:
- Polymyositis development is likely regulated by multi-gene expression.
- NF-kappaB, TNF-alpha, and IL-1alpha are identified as potential candidate molecular markers for polymyositis.
More Related Videos
09:33Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor
Published on: August 25, 2023
11:35Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)
Published on: August 21, 2016